1. Home
  2. MYRG vs CORT Comparison

MYRG vs CORT Comparison

Compare MYRG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MYR Group Inc.

MYRG

MYR Group Inc.

HOLD

Current Price

$338.95

Market Cap

3.9B

Sector

Industrials

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$46.50

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYRG
CORT
Founded
1891
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.7B
IPO Year
2008
2001

Fundamental Metrics

Financial Performance
Metric
MYRG
CORT
Price
$338.95
$46.50
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
$262.43
$96.50
AVG Volume (30 Days)
230.0K
956.9K
Earning Date
04-29-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
311.48
N/A
EPS
7.53
0.82
Revenue
$1,531,169,000.00
$761,407,000.00
Revenue This Year
$11.87
$26.08
Revenue Next Year
$8.48
$26.98
P/E Ratio
$44.27
$56.95
Revenue Growth
N/A
12.79
52 Week Low
$131.96
$28.66
52 Week High
$349.15
$91.00

Technical Indicators

Market Signals
Indicator
MYRG
CORT
Relative Strength Index (RSI) 65.95 65.55
Support Level $255.59 $32.40
Resistance Level N/A $47.06
Average True Range (ATR) 10.35 1.58
MACD 0.38 0.05
Stochastic Oscillator 73.83 86.39

Price Performance

Historical Comparison
MYRG
CORT

About MYRG MYR Group Inc.

MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution networks and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: